Overview
- The NB.1.8.1 variant, first identified in January 2025, has been detected in multiple countries, including at least four cases in France.
- The World Health Organization has placed the variant under surveillance due to potential higher transmissibility, though it assesses the global public health risk as low.
- Current COVID-19 vaccines are expected to remain effective against NB.1.8.1, with no evidence suggesting it causes more severe illness.
- The French government continues its vaccination campaign for individuals aged 80 and above and immunocompromised people, running until June 14, 2025.
- The variant has been linked to a resurgence of COVID-19 cases in parts of Asia, but indicators in France remain low for now.